Want to join the conversation?
$ORCL FY15 10-K: Cash provided by Op. Activities was $14,336MM in FY15 vs. $14,921MM in FY14. Cash used for Investing Activities was $19,047MM in FY15 vs. $7,539MM in FY14. Cash provided by Financing Activities was $9,850MM in FY15 vs. cash used for Financing Activities of $4,068MM in FY14.Free cash flow was $12,945MM in FY15 vs. $14,341MM in FY14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.